Kosmicki JA, Samocha KE, Howrigan DP, et al. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet. 2017;49(4):504-510. doi:10.1038/ng.3789
Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18(3):147-157. doi:10.1038/nrn.2016.183
St Pourcain B, Robinson EB, Anttila V, et al. ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol Psychiatry. 2018;23(2):263-270. doi:10.1038/mp.2016.198
Kaiser T, Feng G. Modeling psychiatric disorders for developing effective treatments. Nat Med. 2015;21(9):979-88. doi:10.1038/nm.3935
Doan RN, Bae BI, Cubelos B, et al. Mutations in Human Accelerated Regions Disrupt Cognition and Social Behavior. Cell. 2016;167(2):341-354.e12. doi:10.1016/j.cell.2016.08.071
Mei Y, Monteiro P, Zhou Y, et al. Adult restoration of Shank3 expression rescues selective autistic-like phenotypes. Nature. 2016;530(7591):481-4. doi:10.1038/nature16971
Penney J, Tsai LH. JAKMIP1: Translating the Message for Social Behavior. Neuron. 2015;88(6):1070-2. doi:10.1016/j.neuron.2015.12.003
Zhou Y, Kaiser T, Monteiro P, et al. Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects. Neuron. 2016;89(1):147-62. doi:10.1016/j.neuron.2015.11.023
D’Gama AM, Pochareddy S, Li M, et al. Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. Neuron. 2015;88(5):910-7. doi:10.1016/j.neuron.2015.11.009
McGrath LM, Braaten EB, Doty ND, et al. Extending the ’cross-disorder’ relevance of executive functions to dimensional neuropsychiatric traits in youth. J Child Psychol Psychiatry. 2016;57(4):462-71. doi:10.1111/jcpp.12463